Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases

BACKGROUND: To investigate the significance of metastatic sites and their numbers to the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 232 patients who received ICI monotherapy or ICI-based combination therapy were r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Transl Med
Main Authors: Qiao, Meng, Zhou, Fei, Hou, Likun, Li, Xuefei, Zhao, Chao, Jiang, Tao, Gao, Guanghui, Su, Chunxia, Wu, Chunyan, Ren, Shengxiang, Zhou, Caicun
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859789/
https://ncbi.nlm.nih.gov/pubmed/33553327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1471
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki